Susan L. Limb

1.1k total citations
33 papers, 697 citations indexed

About

Susan L. Limb is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Susan L. Limb has authored 33 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 16 papers in Physiology and 12 papers in Immunology and Allergy. Recurrent topics in Susan L. Limb's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), Asthma and respiratory diseases (13 papers) and Allergic Rhinitis and Sensitization (9 papers). Susan L. Limb is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), Asthma and respiratory diseases (13 papers) and Allergic Rhinitis and Sensitization (9 papers). Susan L. Limb collaborates with scholars based in United States, Switzerland and United Kingdom. Susan L. Limb's co-authors include Badrul A. Chowdhury, Robert A. Wood, Steven D. Nathan, Peyton A. Eggleston, John L. Stauffer, Robert A. Wise, Elizabeth Morgenthien, Ting-Chang Sheu, Marsha E. Reichman and Paul W. Noble and has published in prestigious journals such as JAMA, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Susan L. Limb

32 papers receiving 677 citations

Peers

Susan L. Limb
Mona Al‐Ahmad Kuwait
Harriet Hédin Sweden
Hikmet Tekin Nacaroğlu Türkiye
Xavier Jaumont Switzerland
Amit Parulekar United States
Patrick St. Louis Canada
Jon D. Herrington United States
Giancarlo Cacciani Italy
Josefina Cernadas Portugal
L. Verresen Belgium
Mona Al‐Ahmad Kuwait
Susan L. Limb
Citations per year, relative to Susan L. Limb Susan L. Limb (= 1×) peers Mona Al‐Ahmad

Countries citing papers authored by Susan L. Limb

Since Specialization
Citations

This map shows the geographic impact of Susan L. Limb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan L. Limb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan L. Limb more than expected).

Fields of papers citing papers by Susan L. Limb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan L. Limb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan L. Limb. The network helps show where Susan L. Limb may publish in the future.

Co-authorship network of co-authors of Susan L. Limb

This figure shows the co-authorship network connecting the top 25 collaborators of Susan L. Limb. A scholar is included among the top collaborators of Susan L. Limb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan L. Limb. Susan L. Limb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Limb, Susan L., Victoria A. Assimon, Janet M. Leeds, et al.. (2024). A Phase 1 Study in Healthy Adults of the Safety, Tolerability, and Pharmacokinetics of MZE829, an APOL1 Inhibitor, for the Treatment of APOL1-Mediated Kidney Disease (AMKD). Journal of the American Society of Nephrology. 35(10S).
2.
Chinthrajah, R. Sharon, Stacie M. Jones, Edwin Kim, et al.. (2022). Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy. Journal of Allergy and Clinical Immunology. 149(6). 2166–2170.e1. 45 indexed citations
3.
4.
Nathan, Steven D., Ulrich Costabel, Carlo Albera, et al.. (2019). Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment. Respiratory Medicine. 153. 44–51. 55 indexed citations
5.
Pan, Lin, et al.. (2018). Effect of pirfenidone on gastric emptying in a rat model. Pulmonary Pharmacology & Therapeutics. 51. 41–47. 4 indexed citations
6.
Haselkorn, Tmirah, Susan L. Limb, John L. Stauffer, et al.. (2018). Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. Pulmonary Therapy. 4(1). 103–114. 3 indexed citations
7.
Nathan, Steven D., Ulrich Costabel, Carlo Albera, et al.. (2018). EFFECT OF PIRFENIDONE ON EXERCISE CAPACITY AND DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) AND MORE ADVANCED LUNG FUNCTION IMPAIRMENT. CHEST Journal. 154(4). 432A–433A. 1 indexed citations
8.
Nathan, Steven D., Ulrich Costabel, Ian Glaspole, et al.. (2018). Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis. CHEST Journal. 155(4). 712–719. 23 indexed citations
9.
Busse, William W., Allan T. Luskin, Robert S. Zeiger, et al.. (2017). Decreased Asthma Exacerbations and Hospitalizations in PROSPERO (Prospective Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). Journal of Allergy and Clinical Immunology. 139(2). AB8–AB8. 2 indexed citations
10.
Liu, Xiaofei, Changning Guo, Badrul A. Chowdhury, et al.. (2017). Valved Holding Chambers and In Vitro Metered Dose Inhaler Performance: Effects of Flow Rate and Inhalation Delay. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 30(6). 399–410. 7 indexed citations
11.
Raimundo, Karina, et al.. (2017). Adherence and Persistence to Antifibrotic Treatments for Idiopathic Pulmonary Fibrosis. CHEST Journal. 152(4). A441–A441. 5 indexed citations
12.
Chipps, Bradley E., Robert S. Zeiger, Allan T. Luskin, et al.. (2017). Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO. Annals of Allergy Asthma & Immunology. 119(6). 524–532.e2. 23 indexed citations
13.
Lee, Sau L., Robert Lionberger, Stephanie Choi, et al.. (2015). International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences. The AAPS Journal. 17(3). 546–557. 46 indexed citations
14.
Doub, William H., et al.. (2014). Developing an In Vitro Understanding of Patient Experience with Hydrofluoroalkane-Metered Dose Inhalers. Journal of Pharmaceutical Sciences. 103(11). 3648–3656. 4 indexed citations
15.
16.
Limb, Susan L., et al.. (2007). Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma. Journal of Allergy and Clinical Immunology. 120(6). 1378–1381. 110 indexed citations
17.
Limb, Susan L., et al.. (2006). Long-Term Immunologic Effects of Broad-Spectrum Aeroallergen Immunotherapy. International Archives of Allergy and Immunology. 140(3). 245–251. 12 indexed citations
18.
Limb, Susan L., Robert A. Wood, Robert A. Wise, et al.. (2005). Adult asthma severity in individuals with a history of childhood asthma. Journal of Allergy and Clinical Immunology. 115(1). 61–66. 51 indexed citations
19.
Limb, Susan L., Kyle E. Brown, Robert A. Wood, et al.. (2005). Irreversible lung function deficits in young adults with a history of childhood asthma. Journal of Allergy and Clinical Immunology. 116(6). 1213–1219. 40 indexed citations
20.
Limb, Susan L., et al.. (2005). Immunotherapy with a candidate extract of natural rubber latex (NRL). Journal of Allergy and Clinical Immunology. 115(2). S111–S111. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mona Al‐Ahmad Breakdown of academic impact, for papers by Harriet Hédin Breakdown of academic impact, for papers by Hikmet Tekin Nacaroğlu Breakdown of academic impact, for papers by Xavier Jaumont Breakdown of academic impact, for papers by Amit Parulekar Breakdown of academic impact, for papers by Patrick St. Louis Breakdown of academic impact, for papers by Jon D. Herrington Breakdown of academic impact, for papers by Giancarlo Cacciani Breakdown of academic impact, for papers by Josefina Cernadas Breakdown of academic impact, for papers by L. Verresen
Rankless by CCL
2026